Model
Edge
Moonlake Immunotherapeutics
MLTX
Filing Type
8-K
Filing Date
11/4/2025
Updated
11/5/25, 3:26 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts
EX-1.1
UNDERWRITING AGREEMENT, DATED NOVEMBER 5, 2025, BY AND BETWEEN MOONLAKE IMMUNOTHERAPEUTICS AND LEERINK PARTNERS LLC
EX-5.1
OPINION OF WALKERS (CAYMAN) LLP
GRAPHIC
Graphic